INR 910.0
(-0.9%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.33 Billion INR | -23.79% |
2022 | 3.44 Billion INR | 12.99% |
2021 | 3.04 Billion INR | 19.15% |
2020 | 2.55 Billion INR | 27.72% |
2019 | 2 Billion INR | 25.48% |
2018 | 1.59 Billion INR | 871.97% |
2017 | 164.22 Million INR | -54.45% |
2016 | 360.49 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 968.71 Million INR | 0.95% |
2024 Q1 | 392.44 Million INR | -44.67% |
2023 Q3 | 893.98 Million INR | 2.82% |
2023 Q4 | 709.3 Million INR | -20.66% |
2023 FY | 2.62 Billion INR | -23.79% |
2023 Q1 | 787.94 Million INR | -10.1% |
2023 Q2 | 869.47 Million INR | 10.35% |
2022 Q1 | 854.68 Million INR | 9.98% |
2022 Q4 | 876.46 Million INR | 5.08% |
2022 FY | 3.44 Billion INR | 12.99% |
2022 Q3 | 834.06 Million INR | -5.12% |
2022 Q2 | 879.04 Million INR | 2.85% |
2021 Q1 | 786.83 Million INR | 117.66% |
2021 FY | 3.04 Billion INR | 19.15% |
2021 Q4 | 777.13 Million INR | 3.14% |
2021 Q3 | 753.49 Million INR | 3.12% |
2021 Q2 | 730.71 Million INR | -7.13% |
2020 FY | 2.55 Billion INR | 27.72% |
2020 Q4 | 361.5 Million INR | 0.0% |
2019 FY | 2 Billion INR | 25.48% |
2019 Q4 | 1.47 Billion INR | 0.0% |
2018 FY | 1.59 Billion INR | 871.97% |
2017 FY | 164.22 Million INR | -54.45% |
2016 FY | 360.49 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Dr. Lal PathLabs Limited | 4.13 Billion INR | 67.725% |
Metropolis Healthcare Limited | 3.3 Billion INR | 59.568% |
Thyrocare Technologies Limited | 1.59 Billion INR | 16.526% |
Vijaya Diagnostic Centre Limited | 985.79 Million INR | -35.389% |
Vimta Labs Limited | 1.05 Billion INR | -26.205% |